Novo Nordisk Stock Jumped After Earnings — But Its CEO Won't Give 2027 Guidance. Here's What Investors Should Know
The Wegovy maker raised its outlook again and the stock jumped. But its CEO refused to forecast next year, and handed investors six clues instead.
- Novo Nordisk raises 2026 outlook as Wegovy pill beats forecasts · reuters.com · 1 day ago
- Novo Nordisk hikes 2026 outlook again as Wegovy pill beats forecasts · reuters.com · 1 day ago